GU CONNECT has summarised the highlights of the recent ASCO GU 2018 meeting for you.


Renal Cell Carcinoma by Associate Professor Brian Costello, Mayo Clinic, USA

 

Brian A. Costello, M.D., M.S. is a Consultant in the Division of Medical Oncology at Mayo Clinic Rochester and is an Associate Professor of Oncology and Urology. He received his medical degree from the Medical College of Wisconsin and completed his internal medicine residency at the University of New Mexico School of Medicine. He then completed his medical oncology fellowship at Mayo Clinic. Dr Costello was subsequently a Mayo Clinic Scholar during which time he focused on early phase clinical trials and genitourinary malignancies. Dr Costello is currently the Chair of the Genitourinary Tumor Group of the Division of Medical Oncology at Mayo Clinic. He serves as a member of the NCCN Kidney Cancer Panel, the National Cancer Institute’s Renal Task Force, as well as the GU Cancers Core Committee of the Alliance for Clinical Trials in Oncology. He also previously served on the NCI Prostate Task Force from 2013 to 2016. He is actively involved in clinical and translational research and has a busy practice caring for patients with genitourinary cancers. Dr Costello is actively involved in early drug development, especially in genitourinary malignancies. He is the Lead Investigator of the NCI-sponsored Mayo Phase II Program and is a member of the NCI’s Investigational Drug Steering Committee.

Programme summary
  • clock Duration 5 MIN
  • clock Language(s) flag
Watch the video now
Other episodes of this series
A CONNECT Update from ASCO GU 2018

A CONNECT Update from ASCO GU 2018

Episode 2 Current Episode
Update from ASCO GU 2018

Update from ASCO GU 2018

Episode 4: Urothelial Carcinoma
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU CONNECT

GU CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

podcast Video podcast
Oncology 
Metastatic TNBC cannot wait

Optimising 1st line TROP2 ADC decisions in metastatic triple-negative breast cancer

Experts
Prof. Giuseppe Curigliano, Prof. Javier Cortés
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Oct 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from AstraZeneca.
conference-update Conference update

Episode

3

of 3

episode
Oncology 
How are new data shaping the landscape in HER2-mutant NSCLC?

Insights from WCLC 2026

Experts
Dr Joshua Sabari
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2026

Educational programme supported by an Independent Educational Grant from Bayer.